PRESS RELEASE published on 12/13/2024 at 07:00, 1 year 10 months ago Communiqué de presse : Le tolebrutinib obtient la désignation de « Médicament innovant » de la FDA pour le traitement de la sclérose en plaques secondairement progressive sans poussées Le tolebrutinib reçoit la désignation 'Médicament innovant' de la FDA pour traiter la SEP-SP sans poussées, grâce aux résultats positifs de l'étude HERCULES. Sanofi prévoit de finaliser les soumissions réglementaires aux États-Unis et en Europe FDA Sanofi Tolebrutinib Médicament Innovant SEP-SP
BRIEF published on 12/11/2024 at 07:05, 1 year 11 months ago Examen accéléré pour deux vaccins combinés de Sanofi contre la grippe et le COVID-19 COVID-19 Sanofi Grippe Vaccins Combinés Examen Accéléré
BRIEF published on 12/11/2024 at 07:05, 1 year 11 months ago Sanofi's two combination vaccines against influenza and COVID-19 receive expedited review COVID-19 Sanofi Flu Combined Vaccines Expedited Review
PRESS RELEASE published on 12/11/2024 at 07:00, 1 year 11 months ago Communiqué de presse : Examen accéléré accordé aux États-Unis à deux candidats-vaccins combinés pour la prévention de la grippe et du COVID-19 La FDA accorde un examen accéléré à deux candidats-vaccins combinés de Sanofi pour la prévention de la grippe et du COVID-19. Études en cours sur la sécurité et la réponse immunitaire FDA COVID-19 Sanofi Grippe Vaccins Combinés
PRESS RELEASE published on 12/11/2024 at 07:00, 1 year 11 months ago Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US Sanofi's two combination vaccine candidates targeting influenza and COVID-19 granted Fast Track designation in the US. Candidates combine licensed vaccines to assess safety and immunogenicity in older adults COVID-19 Sanofi Influenza Combination Vaccine Fast Track Designation
BRIEF published on 12/09/2024 at 20:11, 1 year 11 months ago Sarclisa Combinations Show Promise in Multiple Myeloma Treatment Clinical Study Multiple Myeloma Sarclisa MRD Negativity Treatment Efficacy
BRIEF published on 12/09/2024 at 20:11, 1 year 11 months ago Les combinaisons Sarclisa se révèlent prometteuses dans le traitement du myélome multiple Étude Clinique Myélome Multiple Sarclisa Négativité MRD Efficacité Du Traitement
PRESS RELEASE published on 12/09/2024 at 20:06, 1 year 11 months ago Press Release: ASH: Sarclisa combinations demonstrated significant benefits in newly diagnosed multiple myeloma patients New data presented at ASH demonstrates significant clinical benefit with Sarclisa-based combinations in newly diagnosed multiple myeloma patients, highlighting deep and durable responses and improved outcomes Multiple Myeloma Sarclisa ASH MRD Negativity Clinical Benefit
BRIEF published on 12/07/2024 at 17:35, 1 year 11 months ago Rilzabrutinib : avancées prometteuses dans le traitement de la TPI Sécurité Efficacité Phase III Rilzabrutinib TPI
BRIEF published on 12/07/2024 at 17:35, 1 year 11 months ago Rilzabrutinib: Promising Advances in the Treatment of IPT Security Efficiency Phase III Rilzabrutinib TPI
Published on 11/11/2026 at 03:30, 3 hours 40 minutes ago CoTec Holdings Corp. Files Third Quarter Financial Statements and MD&A and Provides Market Commentary
Published on 11/11/2026 at 00:40, 6 hours 30 minutes ago Upgraded Tunkillia MRE Validates Optimised Scoping Study
Published on 11/10/2026 at 23:30, 7 hours 40 minutes ago CCL Industries Announces 2026 Third Quarter Results
Published on 11/10/2026 at 23:00, 8 hours 10 minutes ago Vanta Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/10/2026 at 23:00, 8 hours 10 minutes ago Battery X Metals Announces Appointment of Chief Financial Officer and Corporate Secretary
Published on 11/11/2026 at 06:45, 24 minutes ago Grand City Properties S.A. announces 9M 2026 strong operational results with increased guidance for FY 2026
Published on 11/11/2026 at 06:44, 25 minutes ago Grand City Properties S.A. announces 9M 2026 strong operational results with increased guidance for FY 2026
Published on 11/11/2026 at 03:25, 3 hours 44 minutes ago Experts Gather in Nanjing to Explore the Cultural Heritage of the Yangtze River
Published on 11/11/2026 at 00:15, 6 hours 54 minutes ago Lean Focus Launches Asia Pacific: Local Expertise. Global Impact.
Published on 11/10/2026 at 23:15, 7 hours 54 minutes ago GSMA MWC26 Doha welcomed over 10,000 attendees, as world-first ITU co-location puts MENA at the centre of global connectivity policy and innovation
Published on 11/10/2026 at 18:00, 13 hours 10 minutes ago Déclaration du nombre total des droits de vote et du nombre d’actions au 31 octobre 2026
Published on 11/10/2026 at 17:45, 13 hours 25 minutes ago Damartex / Descriptif du programme de rachat d'actions
Published on 11/10/2026 at 17:35, 13 hours 35 minutes ago ENGIE - Déclaration du nombre total d'actions et de droits de vote au 31 octobre 2026
Published on 11/10/2026 at 17:31, 13 hours 38 minutes ago CNP Assurances SA annonce le succès de l’émission d’une obligation subordonnée Tier 2 de 500 M€.